GBCS (Selectis Health) Tariff Resilience Score: 8/10 (As of Jul. 04, 2026)


GBCS Selectis Health Inc GBCS
45 GF Score
Price $5.21
GF Value $2.14
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Selectis Health Tariff Resilience Score?

Selectis Health GBCS 45 Tariff Resilience Score is 8 as of Jul. 04, 2026. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 675 Healthcare Providers & Services companies, Selectis Health ranks better than 96.59% on this metric.

Selectis Health has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Selectis Health has Selectis Health operates in the healthcare sector, which is less affected by tariffs. While some medical equipment may be imported, the impact is limited, and the company can leverage domestic suppliers if needed.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Selectis Health might have Highly Resilient.

Selectis Health  (OTCPK:GBCS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Selectis Health Tariff Resilience Score Related Terms

GBCS vs CCM, BMGL, AMS: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Selectis Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Selectis Health Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Selectis Health's Tariff Resilience Score falls into.


GBCS
45GF Score
Selectis Health Inc GBCS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Selectis Health (GBCS) has a Tariff Resilience Score of 8 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Selectis Health ranks #23 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 3.4%.
Is Selectis Health's Tariff Resilience Score too high?
Selectis Health's current Tariff Resilience Score is 8. Based on the distribution chart, Selectis Health ranks #23 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Tariff Resilience Score compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #23 out of 675 companies for Tariff Resilience Score. This places Selectis Health in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Selectis Health's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.21 — trading 143.5% above its estimated fair value. The current Tariff Resilience Score is 8. Selectis Health's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Selectis Health (GBCS), the current Tariff Resilience Score is 8 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.21 is trading 143.5% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • Tariff Resilience Score: 8
  • GF Value™: $2.14 vs. price of $5.21 (143.5% above fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score

Get the complete analysis for GBCS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$2.14
GF Value